Union Bancaire Privee’s Boston Scientific BSX Stock Holding History

Union Bancaire Privee’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.58M	Sell	62,129 -173,105	-74%	-$9.4M	0.03%	222
2026 Q1	$14.4M	Sell	235,234 -13,263	-5%	-$1.06M	0.2%	79
2025 Q4	$23.4M	Buy	248,497 +32,425	+15%	+$3.18M	0.28%	68
2025 Q3	$21.1M	Sell	216,072 -7,862	-4%	-$814K	0.3%	60
2025 Q2	$23.2M	Sell	223,934 -14,747	-6%	-$1.49M	0.34%	60
2025 Q1	$23.2M	Sell	238,681 -143,812	-38%	-$14.5M	0.45%	42
2024 Q4	$33.1M	Buy	+382,493	New	+$33.7M	0.58%	35

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Milford Funds Auckland $6.14B AUM

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Union Bancaire Privee's BSX Position: Q2 2026 in Review

Union Bancaire Privee reduced its Boston Scientific (BSX) stake by 74% in Q2 2026, selling an estimated $9.4M and leaving 62,129 shares worth $2.58M. The position accounts for 0.03% of the portfolio, ranked #222.

Union Bancaire Privee first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $33.1M in Q4 2024. 495 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Union Bancaire Privee held 62,129 shares of Boston Scientific worth $2.58M as of Q2 2026.
Union Bancaire Privee sold 173,105 Boston Scientific shares in Q2 2026, an estimated $9.4M.
Boston Scientific made up 0.03% of Union Bancaire Privee's portfolio in Q2 2026, its #222 holding.
Union Bancaire Privee first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
Union Bancaire Privee's Boston Scientific position peaked at $33.1M in Q4 2024.
495 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.